tetradecanoylphorbol acetate has been researched along with sc 236 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, XM; Jiang, SH; Jiang, Xh; Kung, HF; Lam, SK; Lin, MC; Wong, BC | 1 |
Cui, JT; Jiang, SH; Jiang, XH; Kung, HF; Lam, SK; Lin, MC; Tu, SP; Wong, BC; Wong, WM; Yuen, MF | 1 |
Choi, IY; Hong, SH; Jeong, HJ; Kim, HM; Kim, SJ; Lee, KM; Park, RK | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and sc 236
Article | Year |
---|---|
Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA, Neoplasm; Enzyme Activation; Humans; I-kappa B Kinase; I-kappa B Proteins; Isoenzymes; Membrane Proteins; Neoplasm Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Binding; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Pyrazoles; Stomach Neoplasms; Sulfonamides; Tetradecanoylphorbol Acetate; Transcription Factor RelA; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha | 2003 |
Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase.
Topics: Cell Division; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Membrane Proteins; Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Stomach Neoplasms; Sulfonamides; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2004 |
Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase,
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Calcimycin; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dual Specificity Phosphatase 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Genes, Reporter; Humans; Immunohistochemistry; Ionophores; JNK Mitogen-Activated Protein Kinases; Luciferases; Mast Cells; Membrane Proteins; Microscopy, Confocal; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA; Stimulation, Chemical; Sulfonamides; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Thiazoles | 2005 |